X4 Pharmaceuticals’ bet on drug for ultra-rare disease pays off with FDA approval



The drug, called mavorixafor, is the first-ever treatment for a rare disease that makes patients have a tougher time fighting infections.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *